Canaccord
Tenaya stock undervalued despite strong Ph1 safety update, says Canaccord By Investing.com
On Friday, Canaccord Genuity maintained a Buy rating on Tenaya Therapeutics Inc (NASDAQ:TNYA) stock, with a steady price target of…
Read More »
On Friday, Canaccord Genuity maintained a Buy rating on Tenaya Therapeutics Inc (NASDAQ:TNYA) stock, with a steady price target of…
Read More »On Thursday, Canaccord Genuity maintained a Buy rating on shares of Salesforce.com (NYSE:) and increased its price target to $315…
Read More »